![](/images/general/no_picture/200_user.png)
Carlos R Ortiz Rodriguez
Examiner (ID: 10220, Phone: (571)272-3766 , Office: P/2127 )
Most Active Art Unit | 2119 |
Art Unit(s) | 2125, 2119, 2123, 2127, 2122 |
Total Applications | 923 |
Issued Applications | 647 |
Pending Applications | 77 |
Abandoned Applications | 199 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 11066105
[patent_doc_number] => 20160263069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => 'Therapeutic Compositions'
[patent_app_type] => utility
[patent_app_number] => 15/163295
[patent_app_country] => US
[patent_app_date] => 2016-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 24144
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15163295
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/163295 | Therapeutic compositions | May 23, 2016 | Issued |
Array
(
[id] => 11066106
[patent_doc_number] => 20160263070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => 'Therapeutic Compositions'
[patent_app_type] => utility
[patent_app_number] => 15/163454
[patent_app_country] => US
[patent_app_date] => 2016-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 24141
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15163454
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/163454 | Therapeutic compositions | May 23, 2016 | Issued |
Array
(
[id] => 11066097
[patent_doc_number] => 20160263061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => 'DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST'
[patent_app_type] => utility
[patent_app_number] => 15/161778
[patent_app_country] => US
[patent_app_date] => 2016-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10056
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15161778
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/161778 | DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST | May 22, 2016 | Abandoned |
Array
(
[id] => 11066138
[patent_doc_number] => 20160263101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => '8\'-HYDROXY-DIHYDROERGOTAMINE COMPOUNDS AND COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/161389
[patent_app_country] => US
[patent_app_date] => 2016-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 25835
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15161389
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/161389 | 8'-HYDROXY-DIHYDROERGOTAMINE COMPOUNDS AND COMPOSITIONS | May 22, 2016 | Abandoned |
Array
(
[id] => 12765910
[patent_doc_number] => 20180147138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-31
[patent_title] => TRANSDERMAL LIQUID PREPARATION
[patent_app_type] => utility
[patent_app_number] => 15/574801
[patent_app_country] => US
[patent_app_date] => 2016-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3659
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15574801
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/574801 | TRANSDERMAL LIQUID PREPARATION | May 18, 2016 | Abandoned |
Array
(
[id] => 13339651
[patent_doc_number] => 20180221365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => NOVEL SIGMA-2 RECEPTOR BINDERS AND THEIR METHOD OF USE
[patent_app_type] => utility
[patent_app_number] => 15/573504
[patent_app_country] => US
[patent_app_date] => 2016-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40714
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 271
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15573504
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/573504 | NOVEL SIGMA-2 RECEPTOR BINDERS AND THEIR METHOD OF USE | May 10, 2016 | Abandoned |
Array
(
[id] => 11127871
[patent_doc_number] => 20160324846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-10
[patent_title] => 'Pharmaceutical Compositions for the Treatment of CFTR Mediated Diseases'
[patent_app_type] => utility
[patent_app_number] => 15/152092
[patent_app_country] => US
[patent_app_date] => 2016-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 41605
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15152092
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/152092 | Pharmaceutical Compositions for the Treatment of CFTR Mediated Diseases | May 10, 2016 | Abandoned |
Array
(
[id] => 11074234
[patent_doc_number] => 20160271197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-22
[patent_title] => 'Drug Combinations and Uses in Treating a Coughing Condition'
[patent_app_type] => utility
[patent_app_number] => 15/144800
[patent_app_country] => US
[patent_app_date] => 2016-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61562
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15144800
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/144800 | Drug Combinations and Uses in Treating a Coughing Condition | May 1, 2016 | Abandoned |
Array
(
[id] => 11074172
[patent_doc_number] => 20160271136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-22
[patent_title] => 'Drug Combinations and Uses in Treating a Coughing Condition'
[patent_app_type] => utility
[patent_app_number] => 15/144798
[patent_app_country] => US
[patent_app_date] => 2016-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61562
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15144798
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/144798 | Drug Combinations and Uses in Treating a Coughing Condition | May 1, 2016 | Abandoned |
Array
(
[id] => 12170984
[patent_doc_number] => 09889100
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-13
[patent_title] => 'Cannabidiol for treatment of severe and refractory graft-versus-host disease'
[patent_app_type] => utility
[patent_app_number] => 15/143694
[patent_app_country] => US
[patent_app_date] => 2016-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14153
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15143694
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/143694 | Cannabidiol for treatment of severe and refractory graft-versus-host disease | May 1, 2016 | Issued |
Array
(
[id] => 13478873
[patent_doc_number] => 20180290979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => COMPOSITION HAVING COMPOUND ACCELERATING PHOSPHORYLATION OF AMPK AS EFFECTIVE COMPONENT
[patent_app_type] => utility
[patent_app_number] => 15/570674
[patent_app_country] => US
[patent_app_date] => 2016-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10819
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15570674
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/570674 | COMPOSITION HAVING COMPOUND ACCELERATING PHOSPHORYLATION OF AMPK AS EFFECTIVE COMPONENT | Apr 27, 2016 | Abandoned |
Array
(
[id] => 16459459
[patent_doc_number] => 10842787
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-24
[patent_title] => Ophthalmic composition
[patent_app_type] => utility
[patent_app_number] => 15/568381
[patent_app_country] => US
[patent_app_date] => 2016-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 17
[patent_no_of_words] => 49258
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15568381
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/568381 | Ophthalmic composition | Apr 24, 2016 | Issued |
Array
(
[id] => 13490073
[patent_doc_number] => 20180296579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => METHODS OF TREATING IBRUTINIB-RESISTANT DISEASE
[patent_app_type] => utility
[patent_app_number] => 15/568206
[patent_app_country] => US
[patent_app_date] => 2016-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6408
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15568206
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/568206 | METHODS OF TREATING IBRUTINIB-RESISTANT DISEASE | Apr 17, 2016 | Abandoned |
Array
(
[id] => 12603186
[patent_doc_number] => 20180092892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-05
[patent_title] => Compositions and Methods for Treating Anemia
[patent_app_type] => utility
[patent_app_number] => 15/563169
[patent_app_country] => US
[patent_app_date] => 2016-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53532
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -45
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15563169
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/563169 | Compositions and methods for treating anemia | Mar 30, 2016 | Issued |
Array
(
[id] => 12238513
[patent_doc_number] => 20180071376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'TOLEROGENIC NANOPARTICLES FOR TREATING DIABETES MELLITUS'
[patent_app_type] => utility
[patent_app_number] => 15/560276
[patent_app_country] => US
[patent_app_date] => 2016-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 21012
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15560276
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/560276 | TOLEROGENIC NANOPARTICLES FOR TREATING DIABETES MELLITUS | Mar 22, 2016 | Abandoned |
Array
(
[id] => 13476225
[patent_doc_number] => 20180289655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => Methods and Compositions for the Intravenous Administration of Fumarates for the Treatment of Neurological Diseases
[patent_app_type] => utility
[patent_app_number] => 15/559265
[patent_app_country] => US
[patent_app_date] => 2016-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71453
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15559265
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/559265 | Methods and Compositions for the Intravenous Administration of Fumarates for the Treatment of Neurological Diseases | Mar 17, 2016 | Abandoned |
Array
(
[id] => 10996219
[patent_doc_number] => 20160193165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-07
[patent_title] => 'NOVEL POLYMORPHS AND SALTS'
[patent_app_type] => utility
[patent_app_number] => 15/072567
[patent_app_country] => US
[patent_app_date] => 2016-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5342
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15072567
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/072567 | NOVEL POLYMORPHS AND SALTS | Mar 16, 2016 | Abandoned |
Array
(
[id] => 13125631
[patent_doc_number] => 10080729
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-25
[patent_title] => Composition for use in the treatment of intervertebral misalignment
[patent_app_type] => utility
[patent_app_number] => 15/560138
[patent_app_country] => US
[patent_app_date] => 2016-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 20
[patent_no_of_words] => 10820
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15560138
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/560138 | Composition for use in the treatment of intervertebral misalignment | Mar 16, 2016 | Issued |
Array
(
[id] => 10995707
[patent_doc_number] => 20160192654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-07
[patent_title] => 'COMBINATIONS OF PYRIMETHANIL AND MONOTERPENES'
[patent_app_type] => utility
[patent_app_number] => 15/071493
[patent_app_country] => US
[patent_app_date] => 2016-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4660
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15071493
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/071493 | Combinations of pyrimethanil and monoterpenes | Mar 15, 2016 | Issued |
Array
(
[id] => 13457505
[patent_doc_number] => 20180280295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => SINGLE VIAL READY TO USE CABAZITAXEL FORMULATIONS WITH INCREASED STABILITY AND METHODS OF PREPARATIONS
[patent_app_type] => utility
[patent_app_number] => 15/068641
[patent_app_country] => US
[patent_app_date] => 2016-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6366
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15068641
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/068641 | SINGLE VIAL READY TO USE CABAZITAXEL FORMULATIONS WITH INCREASED STABILITY AND METHODS OF PREPARATIONS | Mar 13, 2016 | Abandoned |